camphor 36 MG/ML / capsaicin 0.25 MG/ML / methyl salicylate 180 MG/ML Topical Solution

RxCUI: 1440065
RxNorm name: camphor 36 MG/ML / capsaicin 0.25 MG/ML / methyl salicylate 180 MG/ML Topical Solution
Display name: Camphor/Capsaicin/Methyl salicylate (Topical)
Full name: camphor 36 MG/ML / capsaicin 0.25 MG/ML / methyl salicylate 180 MG/ML Topical Solution
Term type: SCD
Status: Active
Strength: 3.6-0.025-18%
Dose form: Sol
Route: Topical
Updated: 2026-10-15 14:48:13

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 112013
Active start: 112013
Multiple ingredient: YES
Branded: NO

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
camphor	36 MG / 1 ML	camphor	camphor
capsaicin	0.25 MG / 1 ML	capsaicin	capsaicin
methyl salicylate	180 MG / 1 ML	methyl salicylate	methyl salicylate

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Topical Solution	316986

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
camphor	1952
capsaicin	1992
methyl salicylate	29787

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	camphor 36 MG/ML / capsaicin 0.25 MG/ML / methyl salicylate 180 MG/ML Topical Solution	1	NAMES
RxNorm Name	camphor 36 MG/ML / capsaicin 0.25 MG/ML / methyl salicylate 180 MG/ML Topical Solution	1	NAMES
RxNorm Synonym	camphor 3.6 % / capsaicin 0.025 % / methyl salicylate 18 % Topical Solution	1	NAMES
TTY	SCD	1	ATTRIBUTES
RxCUI	1440065	1	CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
11868070110	rxnav_ndcs	yes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	M02AB	Capsaicin and similar agents	ATC1-4		capsaicin
ATC	N01BX	Other local anesthetics	ATC1-4		capsaicin
MEDRT	D002164	Camphor	CHEM	has_ingredient	camphor
MEDRT	D002211	Capsaicin	CHEM	has_ingredient	capsaicin
MEDRT	D012459	Salicylates	CHEM	has_ingredient	methyl salicylate
MEDRT	D059787	Acute Pain	DISEASE	may_treat	methyl salicylate
MEDRT	D001168	Arthritis	DISEASE	may_treat	methyl salicylate
MEDRT	D001416	Back Pain	DISEASE	may_treat	methyl salicylate
MEDRT	D003288	Contusions	DISEASE	may_treat	methyl salicylate
MEDRT	D003929	Diabetic Neuropathies	DISEASE	may_treat	capsaicin
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	camphor
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	methyl salicylate
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	capsaicin
MEDRT	D006562	Herpes Zoster	DISEASE	may_treat	capsaicin
MEDRT	D007249	Inflammation	DISEASE	may_treat	methyl salicylate
MEDRT	D009120	Muscle Cramp	DISEASE	may_treat	methyl salicylate
MEDRT	D009437	Neuralgia	DISEASE	may_treat	capsaicin
MEDRT	D010146	Pain	DISEASE	may_prevent	capsaicin
MEDRT	D010146	Pain	DISEASE	may_treat	camphor
MEDRT	D010146	Pain	DISEASE	may_prevent	camphor
MEDRT	D013180	Sprains and Strains	DISEASE	may_treat	methyl salicylate
MEDRT	D014076	Tooth Diseases	DISEASE	may_treat	camphor
MEDRT	N0000000160	Cyclooxygenase Inhibitors	MOA	has_moa	methyl salicylate
MEDRT	N0000000105	Neurotransmitter Transporter Interactions	MOA	has_moa	capsaicin
MEDRT	N0000000108	Prostaglandin Receptor Antagonists	MOA	has_moa	methyl salicylate
MEDRT	N0000009915	Unknown Cellular or Molecular Interaction	MOA	has_moa	camphor
MEDRT	N0000008836	Decreased Prostaglandin Production	PE	has_pe	methyl salicylate
MEDRT	N0000008889	Decreased Sensory-Somatic Nervous System Organized Electrical Activity	PE	has_pe	capsaicin
MEDRT	N0000008889	Decreased Sensory-Somatic Nervous System Organized Electrical Activity	PE	has_pe	camphor
MEDRT	N0000009006	Decreased Thromboxane Production	PE	has_pe	methyl salicylate

Group, Type, Concept table
Group	Type	Concept	Source
DF	DF	Topical Solution	rxnav_allrelated
DFG	DFG	Topical Product	rxnav_allrelated
IN	IN	camphor	rxnav_allrelated
IN	IN	capsaicin	rxnav_allrelated
IN	IN	methyl salicylate	rxnav_allrelated
MIN	MIN	camphor / capsaicin / methyl salicylate	rxnav_allrelated
SCD	SCD	camphor 36 MG/ML / capsaicin 0.25 MG/ML / methyl salicylate 180 MG/ML Topical Solution	rxnav_allrelated
SCDC	SCDC	camphor 36 MG/ML	rxnav_allrelated
SCDC	SCDC	capsaicin 0.25 MG/ML	rxnav_allrelated
SCDC	SCDC	methyl salicylate 180 MG/ML	rxnav_allrelated
SCDF	SCDF	camphor / capsaicin / methyl salicylate Topical Solution	rxnav_allrelated
SCDG	SCDG	camphor / capsaicin / methyl salicylate Topical Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	36 MG/ML / 0.25 MG/ML / 180 MG/ML
ATTRIBUTES	GENERAL_CARDINALITY	MULTI
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
NAMES	Prescribable Synonym	camphor 3.6 % / capsaicin 0.025 % / methyl salicylate 18 % Topical Solution
SOURCES	Source	Micromedex RED BOOK